Nurix Therapeutics NRIX
NASDAQ NRIX
$25.64 +0.32 (+1.26%)
As of: Sep 4, 2026 · 12:49 PM EDT

Nurix Therapeutics (NRIX) EPS (Diluted) (2020 - 2026)

Analysis

Nurix Therapeutics (NRIX) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.72 Bn 77.72 Bn 3.93 Bn 12.23
3 Argenx Se 63.56 Bn 58.38 Bn 1.37 Bn 7.15
4 Moderna 57.87 Bn 52.73 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.06 Bn 44.06 Bn - -3.06
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.50 Bn 32.20 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.54 Bn 27.70 Bn - 0.15
9 Insmed 27.49 Bn 26.33 Bn 358.27 Mn -0.06
10 Nurix Therapeutics 2.85 Bn 2.41 Bn - -0.81
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -0.81
Feb 28, 2026 -0.79
Nov 30, 2025 -0.90
Aug 31, 2025 -1.03
May 31, 2025 -0.52
Feb 28, 2025 -0.67
Nov 30, 2024 -0.87
Aug 31, 2024 -0.67
May 31, 2024 -0.71
Feb 29, 2024 -0.76
Nov 30, 2023 -0.77
Aug 31, 2023 -0.68
May 31, 2023 -0.45
Feb 28, 2023 -0.75
Nov 30, 2022 -0.96
Aug 31, 2022 -0.90
May 31, 2022 -1.01
Feb 28, 2022 -0.95
Nov 30, 2021 -0.88
Aug 31, 2021 -0.65